CD Biosynsis offers high-efficiency Saccharomyces cerevisiae Multi-Gene Knockout Strain Construction Services, enabling the rapid and precise elimination of multiple target genes in this robust eukaryotic chassis. Saccharomyces cerevisiae (baker's yeast) is a cornerstone host for industrial biotechnology. Our services leverage the power of multiplexed CRISPR-Cas9 and the yeast's highly efficient Homology-Directed Repair (HDR) mechanism to achieve clean, markerless deletions of multiple genes simultaneously or sequentially. Multi-gene knockouts are fundamental for redirecting metabolic flux, eliminating redundant competing pathways, and creating complex auxotrophic strains necessary for developing superior industrial Saccharomyces cerevisiae strains for chemical, biofuel, and pharmaceutical production.
Get a QuoteConstructing complex chassis strains often requires the stable elimination of numerous genes. Our platform dramatically accelerates this process by employing optimized multiplex CRISPR-Cas9 systems that leverage the intrinsic high efficiency of the Saccharomyces cerevisiae Homology-Directed Repair (HDR) pathway. This allows us to perform several clean gene deletions in a single transformation step, minimizing the manual labor and time associated with sequential editing. This capability is critical for rapidly generating strains with systematically dismantled competing pathways and rationally engineered metabolic flows.
gRNA Cascade Design
Rational design of multiple guide RNAs (gRNAs) simultaneously targeting 2 to 10 genes, enabling single-step knockout of several pathways using one transformation in Saccharomyces cerevisiae.
Multiplex Repair Template
Design of short DNA repair donors linked to selection markers or recycling systems, ensuring simultaneous and clean deletion of multiple loci via the yeast HDR pathway.
Sequential vs. Simultaneous
Strategy optimization based on target lethality; performing simultaneous knockouts for non-essential genes or sequential editing (using marker recycling) for essential/toxic gene deletions.
NLS-Cas9 and gRNA Expression
Use of Cas9 equipped with a Nuclear Localization Signal (NLS) to ensure successful editing complex delivery and activity within the Saccharomyces cerevisiae nucleus.
Marker Recycling Systems
Implementation of marker recycling (e.g., Cre-LoxP or auxotrophic restoration) to allow for multiple, sequential editing rounds without accumulating antibiotic resistance cassettes.
Eukaryotic Transformation
Optimized transformation methods (e.g., electroporation or LiAc/PEG) tailored for high-efficiency uptake of Cas9 and large multiplexed donor DNA fragments by Saccharomyces cerevisiae.
Byproduct Pathway Elimination
Deletion of key genes in redundant or competing pathways (e.g., ethanol production under aerobic conditions) to maximize carbon flux towards the desired product.
Tolerance Engineering
Removal of genes involved in stress response to alter the cell wall or membrane structure, enhancing Saccharomyces cerevisiae tolerance to solvents, acids, or heat.
Auxotrophy & Biosafety
Strategic deletion of nutrient synthesis genes (e.g., URA3, LEU2) to establish auxotrophic strains necessary for laboratory selection and regulatory biosafety compliance.
A systematic process for construction, verification, and stabilization of multi-knockout strains.
1. Rational Target Selection
2. Multiplex System Construction
3. Eukaryotic Transformation and Selection
4. Verification and Stabilization
Identify all native genes (2+) that need to be deleted based on metabolic modeling or experimental data.
Design multiplex gRNA cascade and non-coding homology repair templates for clean deletion via HDR.
Determine the optimal strategy: single-step multiplexing or sequential editing using marker recycling.
Assemble the polycistronic gRNA expression cassette and NLS-Cas9 delivery vector.
Clone the repair template(s) into the appropriate delivery vehicle (if applicable) for homologous recombination.
Verify the integrity of the constructed multi-gene editing plasmids.
Genotype verification via multiplex PCR and definitive Sanger sequencing of all target loci to confirm clean deletions.
Validate the resulting phenotype (e.g., loss of byproduct formation or auxotrophy).
Delivery of the verified, markerless Saccharomyces cerevisiae multi-knockout strain.
High Multiplexing HDR
Optimized CRISPR systems achieve high editing rates, facilitating the simultaneous deletion of multiple genes in a single step via the robust Saccharomyces cerevisiae HDR pathway.
Clean and Markerless
Protocols integrate selection marker recycling, ensuring the final strains are free of residual foreign DNA, maintaining a clean background for industrial use.
Eukaryotic Targeting
Specialized NLS-Cas9 systems ensure efficient delivery of the editing complex to the Saccharomyces cerevisiae nucleus, overcoming the compartmentalization barrier.
Accelerated Timeline
The high efficiency of multiplex editing drastically reduces the number of sequential transformation steps, accelerating the construction of complex chassis strains in Saccharomyces cerevisiae.
1. What makes Saccharomyces cerevisiae suitable for multi-gene knockout?
The primary advantage is its highly active Homology-Directed Repair (HDR) pathway, which is leveraged by CRISPR-Cas9 to perform multiple clean, precise gene deletions simultaneously, a task that is challenging in other microbial hosts.
2. What is the role of the Nuclear Localization Signal (NLS) in the Cas9 system?
As a eukaryotic cell, Saccharomyces cerevisiae sequesters its DNA in the nucleus. The NLS tag is essential for transporting the Cas9 enzyme into the nucleus so it can access and cleave the genomic DNA at the target loci.
3. How do you ensure the final strain is markerless after multiplex editing?
We use marker recycling systems (e.g., based on the Cre-LoxP system or specific counter-selection markers) that allow the temporary selection cassette to be excised or cured, leaving a clean, edited genome.
4. What is the maximum number of genes you can knockout simultaneously in Saccharomyces cerevisiae?
We routinely achieve simultaneous knockouts of 2 to 6 genes in a single multiplex step. The complexity of the target genes dictates the number, with sequential editing used for highly complex strains (10+ deletions).
5. Can you target genes located on mitochondrial DNA or in other organelles?
CRISPR-Cas9 is primarily nuclear-targeted. For organelle DNA (mitochondrial or plastid), specialized editing tools (like TALENs or specific zinc fingers) or non-CRISPR genetic manipulation techniques may be required.
6. How do you verify that all target genes were deleted in a multi-knockout strain?
We use robust genotype verification, typically multiplex PCR (to check the genomic rearrangement size at all loci simultaneously), followed by definitive Sanger sequencing of each edited region to confirm a clean, markerless deletion.
7. What is the typical turnaround time for a 3-gene knockout strain?
Given the high efficiency of the multiplex system in Saccharomyces cerevisiae, the turnaround time is significantly faster than traditional sequential editing methods, often reducing the overall project timeline by weeks.
8. What initial input is required from the client for this service?
The client needs to provide the gene names or locus tags of the genes (2 or more) to be knocked out and the specific Saccharomyces cerevisiae host strain (or wild-type strain) to be used for the modification.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.